Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
30,673,858
-
Shares change
-
+1,383,439
-
Total reported value, excl. options
-
$527,882,858
-
Value change
-
+$3,530,435
-
Put/Call ratio
-
0%
-
Number of buys
-
74
-
Number of sells
-
49
-
Price
-
$17.21
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2019
As of 30 Sep 2019 Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) had 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,673,858 shares of stock of the company.
Largest 10 holders included TRV GP III, LLC, Bellevue Group AG, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Clearbridge Investments, LLC, Partner Fund Management, L.P., Casdin Capital, LLC, ARMISTICE CAPITAL, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 129 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.